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NUTRICIÓN ENTERAL DOMICILIARA EN NIÑOS;
10 AÑOS DE EXPERIENCIA CON 304 PACIENTES
Resumen
Introducción y objetivos: La nutrición enteral domici-
liaria es un soporte nutricional cada vez más utilizado en
población pediátrica. Nuestro objetivo ha sido describir
el perfil de un grupo de pacientes pediátricos que precisa-
ron este tratamiento.
Material y métodos: Se analizaron retrospectivamente
todos los pacientes menores de 18 años que precisaron
tratamiento con nutrición enteral domiciliaria entre
enero 1995 y diciembre 2004. 
Resultados: Se estudiaron 304 pacientes (157 niños). La
edad media al inicio del tratamiento fue de 4,02 ± 4,09
años, con una mediana de 2,5 años; un 28% de los pacien-
tes eran menores de 1 año. Las indicaciones principales
fueron la enfermedad oncológica en 91 pacientes (29,9%)
y la digestiva en 84 (27,6%). Se encontraron diferencias
significativas en función del diagnóstico clínico para la
edad de inicio, el tipo de acceso, el modo de administra-
ción y la fórmula prescrita. El tipo de acceso más utilizado
fue la sonda nasogástrica en 218 pacientes (71,7%). El
régimen de infusión más utilizado fue la nutrición enteral
nocturna en 155 pacientes (51%). Se prescribió principal-
mente fórmula polimérica de adultos o pediátrica en 190
pacientes (62,5%). La duración media del tratamiento fue
de 306 ± 544 días. 
Conclusión: En nuestra serie, el soporte enteral suele
iniciarse a edades muy tempranas. Sus características
variaron en función de la patología del paciente. Conocer
el perfil del paciente pediátrico es importante para dise-
ñar la estrategia más eficaz en el uso de la nutrición ente-
ral domiciliaria. 
(Nutr Hosp. 2012;27:1444-1450)
DOI:10.3305/nh.2012.27.5.5898
Palabras clave: Nutrición enteral domiciliaria. Niños. Nutri-
ción enteral por sonda. Gastrostomía. Yeyunostomía.
Abstract
Background & aims: Home enteral nutrition is used
increasingly in pediatric populations. Our objective was
to describe the profile of pediatric patients requiring this
treatment. 
Material and methods: All patients under 18 years old
requiring treatment with home enteral nutrition between
January 1995 and December 2004 were analyzed retro-
spectively. 
Results: 304 patients were studied (157 boys). The
mean age at the start of treatment was 4.02 ± 4.09 years,
median of 2.5 years; 28% of all patients were under 1
year. The main indications were oncological disease in 91
patients (29.9%) and digestive diseases in 84 (27.6%).
There were significant differences depending on the clini-
cal diagnosis for the start age, type of access, infusion
regime and formula prescribed. Nutrients were delivered
by nasogastric tube in 218 patients (71.7%). Overnight
enteral nutrition was the preferred infusion regime in 155
patients (51%). Adult or pediatric polymeric formulas
were mostly prescribed in 190 patients (62.5%). The
mean treatment duration was 306 ± 544 days. 
Conclusion: In our series, enteral support usually
begins at an early age. Its characteristics varied depend-
ing on patient pathology. Knowledge of the pediatric
patient profile is important to design the most effective
strategy for home enteral nutrition. 
(Nutr Hosp. 2012;27:1444-1450)
DOI:10.3305/nh.2012.27.5.5898
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Abbreviations
EN: Enteral nutrition. 
GT: Gastrostomy. 
HEN: Home enteral nutrition. 
JA: Jejunal access. 
NGT: Nasogastric tube 
Introduction
Enteral nutrition (EN) is the preferred technique for
artificial nutritional support. It consists of administer-
ing nutrients through the digestive tract using a defined
mixture (enteral formula), generally by means of naso-
gastric tube or tubes placed directly through a stoma.1 It
also includes the supply of natural food stuffs using
these artificial accesses.2
Since its application at the onset of the 1970s,3 the
use of EN has continued to grow thanks to, among
other factors, improved knowledge of patient nutri-
tional needs, the appearance of new enteral formulas,
improved healthcare support materials, enhancement
in the approach and nutritional infusion techniques and
the design of multidisciplinary protocols to reduce
complications and evaluate the results.1
Home Enteral Nutrition (HEN) is the prolongation
of enteral nutritional support at the patient’s own home.
This support was previously established in the hospital,
and whose control is carried out by the healthcare team
at the hospital center or at the patient’s own home. The
general objectives of HEN seek to stabilize the base ill-
ness, shorten hospital stays and allow the child to inte-
grate into his/her family and social environment, which
translates into improved quality of life for the child4
and a decrease in treatment costs.5
Despite the increase experienced by HEN in pedi-
atric patients in recent years, publications on this topic
are scarce.6 This study analyzes the profile of a group of
pediatric patients who required HEN in a 10-year
period, according to the variables of age, indication,
type of enteral access device, infusion regime and
nutrients delivered. 
Patients and methods 
A total of 304 patients (157 boys) were studied. The
data of all the patients under 18 years old who required
HEN from January 1995 to December 2004 in a tertiary
hospital was analyzed retrospectively. The study proto-
col was approved by the Hospital Ethics Committee, in
accordance with the Declaration of Helsinki of 1964,
revised in Seoul in 2008. 
The data collected included age, gender, indication,
type of enteral access, infusion regime, nutrients deliv-
ered and duration of the support. HEN indications were
classified as oncological disease, digestive disease,
neurological disorders, failure to thrive, and miscella-
neous causes (fig. 1). Nutrients were delivered by naso-
gastric tube (NGT), gastrostomy (GT) or jejunal access
(JA). NGT was used when the foreseen duration of the
nutritional support was less than 3 months or when GT
was contraindicated or rejected by the parents or
patient. GT was used when the foreseen duration
exceeded 3 months or placement of NGT was not pos-
sible. Four infusion regimes were used: continuous EN
(> 16 hours/day), overnight EN (< 12 hours/day), day
time bolus EN and day time bolus with overnight EN.
For continuous or overnight EN, peristaltic pumps
were used (Frenta System III®, Fresenius; Companion®,
Abbot). Enteral nutrition formulas used during the
study included standard infant formulas, hydrolyzed-
protein formulas, polymeric adult-type and polymeric
pediatric formulas. These products were adapted to the
age and diagnosis of each patient. Standard infant and
hydrolyzed protein-based formulas may have eventu-
ally been concentrated or enriched with carbohydrate
and/or fat units.
Statistical analysis
First, the descriptive statistics, means and typical
deviations among the quantitative variables were cal-
culated, as well as frequencies and percentages among
the qualitative variables. For the comparisons between
groups, F de Fisher-Snedecor was used for quantitative
variables and the relationship between simple variables
was analyzed using X2 for categorical variables. For
statistical analysis we used the Statistical Package for
the Social Sciences (SPSS), version 16.0. For all the
tests carried out, bilateral statistical significance was
set at p < 0.05.
Results
Population
The mean age of patients commencing HEN was
4.02 ± 4.09 years (Q1-Q3: 0.83-6.16) with a median of
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Fig. 1.—Pathologies which led to HEN.
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2.5 years; 28% of the patients were under 1 year old.
The age varied from 2.6 ± 3.2 years in patients with
failure to thrive and 5.9 ± 5.0 years in patients with
neurological disorders. The differences in the start age,
depending on clinical diagnosis, were statistically sig-
nificant (F = 8.292, p = 0.001) (fig. 1). The mean age of
the patients HEN concluded was 4.8 ± 4.4 years. 
The mean duration of the HEN was 306 ± 544 days
(range 3 - 3565): 81 patients (26.6%) received HEN for
less than 30 days and 11 patients (3.6%) for more than
5 years. The differences in the time with HEN depend-
ing on the clinical diagnosis were statistically signifi-
cant (F = 8.175, p = 0.001). At the conclusion of the
study, 42 patients (13.8%) continued with the support;
in 190 patients (62.5%) normal oral feeding was
restored, 32 patients died (10.5%); there was failure of
HEN in 20 (6.6%) and data was not obtained in 20
(6.6%) (moved to another region).
Indications
Indications for administering HEN were oncological
disease in 91 patients (29.9%), digestive disease in 84
(27.6%), neurological disorders in 70 (23.0%), failure to
thrive in 28 (9.2%) and miscellaneous causes in 31
(10.2%). Miscellaneous causes included metabolopathies,
cardio-respiratory, renal disease and immunodeficiency.
Of the oncology patients, 34 (37.4 %) suffered malig-
nant hemopathies, 33 (36.3%) solid tumors and 24
(26.4%) intracranial tumors. Digestive disorders
included gastro-esophageal disease in 28 patients
(33.3%); cystic fibrosis in 20 (23.8%); malabsorption
in 20 (23.8%), which included coeliac disease, milk
allergy, short bowel syndrome or severe diarrhea;
intestinal dysmotility in 7 (8.3%); inflammatory bowel
disease in 6 (7.1%); and hepatic disease in 3 (3.5%). Of
the neurological patients, 23 (32.8 %) presented cere-
bral palsy, 7 (10%) sequels to infectious disease or
traumatic injury, 8 (11.4%) malformations of the cen-
tral nervous system, 6 (8.6%) neuromuscular diseases,
13 (18.6%) neurodegenerative diseases, and 13 (18.6
%) others.
Type of enteral access devices, infusion regime, 
and nutrients delivered
Enteral formula was delivered by NGT tube in 218
patients (71.7%), GT in 82 (27.0%) and JA in 4 (1.3%).
There were statistically significant differences when
the type of enteral access and the indication (clinical
diagnosis) were considered (X2 = 54.111, p = 0.001)
(fig. 2). NGT was the most commonly used access in
most of the diagnoses except in patients with neurolog-
ical pathology; in this type of patient GT was preferred. 
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Fig. 2.—Age of patients at
the beginning of home ente-
ral nutrition according to in-
dividual pathology. t =
3.088, p = 0.003- this age
distribution according to
pathologies reached statisti-
cal significance.
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Infusion regime was continuous EN in 64 patients
(21.1%), overnight EN in 155 (51%), day time bolus
EN in 34 (11.2%) and day time bolus with overnight
EN in 51 (16.8%). There were statistically significant
differences when the administration method and the
indication (clinical diagnosis) were considered (X2 =
54.476, p = 0.001) (fig. 3). All patients with continuous
or overnight EN used a pump. For bolus EN both pump
and syringe were used. 
The nutrients delivered during the study period
comprised standard infant formulas in 50 patients
(16.4%), hydrolyzed-protein formulas in 64 (21.1%)
and polymeric adult-type and polymeric pediatric for-
mulas in 190 (62.5%). Standard infant formulas and
hydrolyzed-protein formulas were, for the most part,
powdered and were reconstituted by the parents
according to the instructions given in writing in the
time of discharge. Standard infant formulas were gen-
erally prescribed for patients with neurological disor-
ders in 13 patients (26.0%) and patients with digestive
disease in 12 (24.0%). Hydrolyzed-protein formulas
were especially indicated for patients with digestive
disease in 41 patients (64.0%). Polymeric adult-type
and polymeric pediatric formulas were prescribed
mainly for patients with oncological disease in 83
patients (43.6%) and patients with neurological disor-
ders in 52 (27.3%). The differences found between
types of formulas, prescribed according to indication,
reached statistical significance (X2 = 100.662, p =
0.001) (fig. 4).
Discussion
The studies into pediatric patients with HEN are
scarce, although recently, Daveluy et al.7 Diamanti et
al.8 Salomon and Garbi9 as well as Szlagatys-
Sidorkiewicz et al.10 have published their experiences
on this topic. Comparison between the various series is
difficult since the itemized classification of the
pathologies varies from on study to another, as well as
the type of diseases cared for at the various hospitals
and the peculiarities of the healthcare organization of
each country or region. 
It is important to point out that this series is the most
important research carried out in Spain with pediatric
patients with HEN. To date, publications about HEN
from the NADYA-SENPE group (Out-patient and
home enteral nutrition and of the Spanish Parenteral
and Enteral Nutrition Society) from the year 199311 up
to 200912 include an extremely limited number of pedi-
atric patients. 
The age of patients in this study was 4.0 ± 4.09 years,
with a median of 2.5 years similar to those in the study
by Salomon and Garbi9 (4.11 ± 4.5 y, with a median of
2 y) and they were younger than in the study of Dav-
eluy et al.7 (5.4 ± 5.3 y, with a median of 3 y) and that of
Szlagatys-Sidorkiewicz et al.10 median age 6 y (range
0.75-18 y) In the Planas et al.13 study, the median age of
the patients under 14 years with HEN was 6.0 ± 4.3
years, older than this study. That the patients are
younger in this study could be due, in part, to the incor-
poration of nutritional care as a part of the general
health care for the early detection and prevention of
malnutrition during the hospitalization of chronic
patients, especially in oncological patients, for the sur-
vival of newborns with special medical and nutritional
needs,14 the creation of a nutritional support team,15 and
the development of the gastrostomy techniques in
small children.16 The age of the patients, on the other
hand, varies greatly according to the individual pathol-
ogy. In this study, the youngest patients were those
Home enteral nutrition in children 1447Nutr Hosp. 2012;27(5):1444-1450
Fig. 3.—Type of enteral access devices according to the indivi-
dual pathology. X2 = 31.349, p = 0.001- the differences found
between routes of administration according to individual patho-
logies reaches statistical significance.
Fig. 4.—Types of formulas prescribed according to the indivi-
dual pathology. X2 = 100.662, p = 0.001- the differences found
between types of formulas according to individual pathologies
reaches statistical significance.
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who were failing to thrive, while the oldest were the
patients with neurological disorder. In the study by
Daveluy et al.7 the youngest patients were those with
hepatic disorders and the oldest were those with
inflammatory bowel disease, while in the study by
Salomon and Garbi9, the patients with a milk allergy
were the youngest and those with cerebral palsy were
the oldest, as in this series. 
The most frequent pathology in this series was
oncology (30%), which only represents 1.5%, 11%
and 1% of the broader series7,8,9 followed by digestive
disease (27.6%) and neurological disorders (23%).
These last two pathologies are the more common in
the works published. Digestive disease represent 29%
in the study by Holden et al.,4 44% in the Diamanti et
al.8 study, 35% in that by Daveluy et al.7 and only
9.6% in the study by Szlagatys-Sidorkiewicz et al.10
This is due to the characteristics of this hospital, since
it is a reference hospital in the treatment of pediatric
oncology patients. In the study with adults by Pironi
et al.17 the greatest prevalence of HEN was observed
in oncological patients and in pediatric patients, the
greatest prevalence was in neurological cases. The
most frequent digestive disease in this study was gas-
troesophageal disease, followed by the cystic fibrosis
and malabsorption; similar results were obtained in
the study by Daveluy et al.7 while in the study by Dia-
manti et al.8 the main causes of digestive disease was
malabsorption followed by gastroesophageal reflux.
In the study by Salomon and Garbi9, it was cystic
fibrosis followed by malabsorption. 
In this study, NGT was the most frequent access in
comparison to a stoma; similar results were reported
by Daveluy et al.7 and Diamanti et al.8. This agrees
with the observations in the BANS register14. This is
due to the fact that gastrostomy is usually proposed
over long periods of time. Some authors indicate that
even in short periods of time, gastrostomy may be
indicated18-20; this period could be reduced greatly in
the most recent recommendations by ESPEN21 (2-3
weeks) and by ESPGHAN22 (4-6 weeks). Despite
these recommendations, all the studies, except that by
Szlagatys-Sidorkiewicz et al.10 (most patients had
neurological problems and a high mean age) carried
out with children, had a higher frequency of nasal
routes. This may be due to the fact that these patients
require short periods of HEN or who present transi-
tory processes (eg, cancer, as in this series), awaiting
a treatment that will resolves their disease (heart
surgery), or until landmarks of maturity are reached
to allow them to completely recover oral feeding.
Gastrostomy is unavoidable in the cases of inter-
rupted esophagus and is of great use in cases of dys-
phagia. In this series, the use of gastrostomy (27.0%
of the total) was lower to what was expected, as,
strictly applying the criteria of duration (> of 3
months), this access technique should have been used
on 42% of these children. These results are inferior to
those of the series by Diamanti et al.8 who carried out
gastrostomy in 38% and lower to the data presented
by Daveluy et al.7 who carried out gastrostomy in
47%. There are multiple reasons to not use gastros-
tomy in more cases: pathologies in which it is con-
traindicated (hepatic alterations due to transplant);
technical difficulties due to anatomical changes (cer-
tain patients with infantile cerebral palsy); prior surg-
eries or massive hepatomegaly; due to indication by
the doctor to prevent medical and psychological com-
plications and above all, due to medical-cultural,
family and social factors. In this regard, the reflec-
tions by Gauderer16 are revealing, because they show
the need for the patient and their environment to be
convinced about using the technique. In this series,
gastrostomy was the most used access in patients
with neurological disease (54.3%), which usually
requires HEN for longer period of time. Jejunal
access constitutes an exceptional option both in this
case and in other series.7-10 Indicated in cases of
severe RGE, gastric dysmotility and pancreatitis, its
use in children has major technical difficulties. It was
used in the last two pathologies. 
In this study, the most used infusion regime was
overnight EN in 51% of the total series; in these cases,
the application of the enteral serves to complete the
child’s oral feeding, which occurs above all in
patients with failure to thrive and digestive pathology,
as opposed to people with neurological disease. This
is due to the fact that children with failure to thrive or
digestive disease are less deteriorated and the indica-
tion of overnight EN is to try to preserve oral feeding
during the day and avoid dysfunctions of alimentary
behavior secondary to the use of the tube. These
results could not be compared with the previous series
because this variable was not included in these stud-
ies. Peristaltic pumps were used for continues admin-
istration in all the children, thus assuring better com-
pliance with the prescription, tolerance of the EN, and
comfort and tranquility of the family in the nocturnal
infusions. This is an extreme that is not clear in other
series,7,8 since the reference to the use of a pump is
made globally. 
Regarding the prescription formula, the most pre-
scribed product in this study was polymeric formulas,
followed by hydrolyzed-protein formulas and standard
infant formulas. The pediatric and adult polymeric
diets are contemplated jointly because the criteria to
indicate one or the other has changed while the study
was undertaken (initially adult diets were indicated
starting from the age of 6 years and later starting from
10).1,23 Also, the study fails to analyze whether the for-
mula was supplemented with fiber or whether they
were hypercaloric preparations, since pediatric prod-
ucts with these characteristics were unavailable in
Spain until after the year 2000.2 Specific indications for
certain pathologies such as hypercaloric presentations
in malnourished oncological patients24 or products with
fiber in children with neurological disorders25 must be
considered in practice. 
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The formulas indicated in these patients were pre-
scribed bearing in mind their age, their digestive func-
tion and the existence of specific nutritional needs.1,2 In
some groups of patients, the type of formula varied
over time, such as the case of cystic fibrosis26 (in which
hydrolyzed diets are currently destined to those cases
of seriously malnourished infants in the first phases of
their nutritional rehabilitation, with short intestine or
allergy to cow milk proteins), and in inflammatory
bowel disease (in which case the polymeric diets reach
the same nutritional and therapeutic objectives as
hydrolyzed or elemental diets).27
With the exception of the polymeric diets, the rest
of the types of formulas used and the supplements
with modular nutrients (carbohydrate and/or fat),
were presented as powder and were prepared by the
parents following the instructions given in writing in
the time of patient hospital discharge as well as to
composition, hygienic measures and change of sys-
tems, this latter performed daily. It is unknown
(because it was not object of this work, nor has it been
researched routinely) whether these products could
have been contaminated, as has been described by
other groups.28 Currently, some preparations are pre-
sented as liquids, ready to use, which constitutes a
great advance from the point of view of safety and
ease of handling. 
One limitation of this study is that the patients come
from a single hospital, which does not allow studies to
be made of either prevalence or incidence of HEN.
Another limitation is that there is no data about compli-
cations in the patients or hospital readmissions. A new
data protocol has been developed to incorporate new
patients and include data from other hospitals.
Conclusion
Over a 10 year period, a large group of pediatric
patients at a tertiary hospital diagnosed with variety of
chronic diseases was treated with HEN. This type of
treatment can be carried out at early ages and can be
prolonged over variable periods of time, even years. 
The access route must be suited to the clinical diag-
nosis and the duration of the support, but the factors of
the patient’s environment must also be considered. The
doctor must individualize the indication and provide
the patient with the best treatment. 
The existence of numerous types of formula and
HEN infusion regimes allow the support to be adjusted
to individual patient needs and requirements. 
This is the first national study in Spain to include
pediatric patients with HEN in which the profile of the
pediatric patient requiring HEN is described according
to age, indication, type of enteral access, infusion
regime, and type of formula prescribed. New studies
within Spain are needed, which allow effective and
safe strategies for pediatric patient with HEN to be
designed. 
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